NACLC
<ѻý class="page-description">North America Conference on Lung Cancerѻý>Nivolumab-ipilimumab with two cycles of chemotherapy improved survival, regardless of histology or PD-L1 status
October 17, 2020
<ѻý class="section_title"> Latest Oncology/Hematology Meeting Coverageѻý>
-
SABCS: San Antonio Breast Cancer Symposium
December 2024
-
ASH: Hematology: American Society of Hematology
December 2024
-
SNO: Society for NeuroOncology
November 2024
-
ASTRO: American Society for Radiation Oncology
September 2024